Regenerative Medical Technology Group Inc.
RMTG
$0.0264
-$0.0126-32.31%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 28.06% | 57.28% | -5.89% | -666.02% | 95.63% |
| Total Depreciation and Amortization | -131.31% | 6.99% | 8.36% | -20.95% | -1.82% |
| Total Amortization of Deferred Charges | -93.34% | -93.59% | 0.64% | 34.10% | -0.07% |
| Total Other Non-Cash Items | -175.00% | 71.43% | -53.33% | 100.10% | -136.65% |
| Change in Net Operating Assets | 3.77% | -4.55% | 8.88% | 10.12% | -0.25% |
| Cash from Operations | 39.03% | 201.88% | -16.30% | 467.35% | -391.09% |
| Capital Expenditure | 6.72% | -1.71% | 10.98% | 79.15% | -210.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 6.72% | -1.71% | 10.98% | 79.15% | -210.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.21% | 481.70% | -22.75% | 107.96% | -655.42% |